Wordt geladen...
The Effect of a High‐Fat Meal on the Pharmacokinetics of Ixazomib, an Oral Proteasome Inhibitor, in Patients With Advanced Solid Tumors or Lymphoma
Ixazomib is the first oral proteasome inhibitor to be investigated in the clinic. This clinical study assessed whether the pharmacokinetics of ixazomib would be altered if administered after a high‐calorie, high‐fat meal. In a 2‐period, 2‐sequence, crossover study design, adult patients with advance...
Bewaard in:
| Gepubliceerd in: | J Clin Pharmacol |
|---|---|
| Hoofdauteurs: | , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley and Sons Inc.
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5069578/ https://ncbi.nlm.nih.gov/pubmed/26872892 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcph.719 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|